CVS Health is topping fourth-quarter earnings forecasts, but the annual outlook from the nation's second-largest drugstore chain is far short of Wall Street expectations.
The company said Wednesday that it expects adjusted earnings to range between $6.68 and $6.88 this year. FactSet says analysts expect earnings of $7.35 per share.
In the final quarter of 2018, CVS Health posted adjusted earnings of $2.14 per share, as revenue jumped more than 12 percent to $54.24 billion.
Analysts expected earnings of $2.09 per share and $54.61 billion in revenue, according to FactSet.
CVS Health Corp., based in Woonsocket, Rhode Island, runs more than 9,900 retail locations and processes over a billion prescriptions annually as a pharmacy benefit manager.
It also has largely completed a roughly $69-billion acquisition of the insurer Aetna.
Before you consider CV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CV wasn't on the list.
While CV currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report